Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly (LLY) sell-off 'overdone' on CVS move on Wegovy - Leerink

May 2, 2025 9:33 AM EDT

Leerink Partners analyst David Risinger reiterated an Outperform rating and $944.00 price target on Eli Lilly (NYSE: LLY), saying yesterday's 12% pullback creates a buying opportunity.

The analyst commented, "Despite LLY downplaying CVS Caremarks action favoring Wegovy over Zepbound, LLY shares declined 11.7% yesterday.... More